Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

2.46
+0.06002.50%
Volume:24.45K
Turnover:60.34K
Market Cap:12.63M
PE:-0.20
High:2.50
Open:2.44
Low:2.39
Close:2.40
Loading ...

CEL-SCI Corporation Announces 1-for-30 Reverse Stock Split Effective May 20, 2025

Reuters
·
20 May

CEL-SCI Announces Combination of Common Stock

THOMSON REUTERS
·
20 May

CEL-SCI Q2 EPS $(0.08) Up From $(0.14) YoY

Benzinga
·
15 May

CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results

THOMSON REUTERS
·
15 May

Press Release: CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results

Dow Jones
·
15 May

Cemig Files 2024 Form 20-F

PR Newswire
·
01 May

BRF S.A. Files 2024 Annual Report with SEC and CVM

TIPRANKS
·
01 May

Press Release: GERDAU S.A. - CONSOLIDATED INFORMATION

Dow Jones
·
29 Apr

Press Release: Itaú Unibanco Holding's 2024 Annual Report on Form 20-F filed with the SEC and the CVM

Dow Jones
·
29 Apr

BRIEF-CEL-SCI Corp To File For Regulatory Approval Of Multikine In Saudi Arabia

Reuters
·
23 Apr

CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market

Business Wire
·
23 Apr

CEL-SCI says publication supports strategy to seek early approval for multikine

TIPRANKS
·
08 Apr

New Study in the Scientific Journal "Cancer Cell" Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses

Business Wire
·
08 Apr

Experian plc EXPERIAN COMPLETES ACQUISITION OF CLEARSALE

Dow Jones
·
02 Apr

BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

Reuters
·
24 Mar

CEL-SCI Reports New Data: Treatment With Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

THOMSON REUTERS
·
24 Mar

BRIEF-CEL-SCI announces closing of $2.5 million offering

Reuters
·
19 Mar

CEL-SCI Announces Closing of $2.5 Million Offering

THOMSON REUTERS
·
19 Mar

CEL-SCI announces pricing of $2.56M common stock offering

TIPRANKS
·
18 Mar

CEL-SCI Announces Pricing of $2.5 Million Offering

THOMSON REUTERS
·
18 Mar